Tests For Cancer - Articles

Sort by: Newest Most Comments Relevance

Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum by Robert W. Posted Sun 08 Feb 2009 8:55pm Health Report: Hormone Replacement Therapy (HRT) & Breast Cancer Stool DNA Testing & Cancer of the Colon & Rectum "A critical weekly review of important new... there are several available options for colorectal cancer screening, colonoscopy remains the “gold standard” screening test, as it allows for evaluation of the entire colon and rectum Read on »

Lawsuit attacks patent giving company control over genetic test for cancer risk by Mike Klein Patient Expert

Posted Tue 02 Mar 2010 10:06pm Read on »

News Note: New NCI Program Will Help Aid Development and Validation of Tests Used in Cancer Clinical Trials by Cancer.gov Posted Sun 20 Jun 2010 9:00pm News Note: New NCI Program Will Help Aid Development and Validation of Tests Used in Cancer Clinical Trials In order to conduct rigorous and robust clinical trials, the tests, or assays, used in those trials must meet optimum standards. To bring those assays and standards in line with 21st century technology, NCI's Division of Cancer Read on »

Blood test for cancer? by Sandi W. Patient Expert

Posted Wed 05 Jan 2011 2:47am There's a new test that is so sensitive it can find one cancer cell in a billion. Veridex and Johnson & Johnson's Ortho Biotech Oncology unit will work on making the test... in Houston and Dana-Farber Cancer Institute in Boston will start using the test this year. If you could find out quickly, "this drug is working, stay on it," or "this drug Read on »

Should I Be Tested for Cancer? : Maybe Not and Here's Why by Dr. Aniruddha M. Medical Doctor

Posted Tue 18 Nov 2008 12:17am Amazon.com: Should I Be Tested for Cancer? : Maybe Not and Here's Why: "The cost of medical malpractice soars as patient lawsuits proliferate, and healthcare providers..., cancer, and you have Americans possessing health coverage routinely undergoing test after test. What of the downside of testing healthy people? Welch, a specialist in cancer Read on »

Personalized blood tests for cancer - whole genome sequencing by Dr. John Z. Medical Doctor

Posted Sun 21 Feb 2010 12:00am Cancer Center have used data from the whole genome sequencing of cancer patients to develop personalized blood tests for cancer they believe can help physicians tailor patients’ treatments. The genome-based blood tests, believed to be the first of their kind, may be used to monitor tumor levels after therapy and determine cancer recurrence. “We believe Read on »

Blood test for cancer creating excitement by Momgoingcrazy Posted Thu 06 Jan 2011 6:34pm http://www.chron.com/disp/story.mpl/nation/7363222.html Blood test for cancer creating excitement Researchers say sensitive and speedy procedure will help treatment By MARILYNN MARCHIONE ASSOCIATED PRESS Jan. 3, 2011, 12:53PM BOSTON — A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones is moving one Read on »

Personalized Blood Tests for Cancer Use Whole Genome Sequencing by MedNews Patient Expert

Posted Mon 29 Nov 1999 4:00pm Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests... tumors into the patients’ blood. Using blood samples from two of the colorectal cancer patients, they amplified DNA found in the blood and determined that these tests were Read on »

Personalized Blood Tests for Cancer Use Whole Genome Sequencing by MedNews Patient Expert

Posted Sun 21 Feb 2010 11:40am Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-based blood tests, believed to be the first Read on »

Colon Cancer Test Predicts Risk of Cancer Recurrence by catattack Posted Fri 19 Jun 2009 10:13pm According to a press release from Genomic Health, the Oncotype DX® colon cancer assay—a genomic test similar to one already in use for breast cancer—has been shown to predict the risk of cancer recurrence among patients with Stage II colon cancer. This test may eventually help guide colon cancer treatment decisions. For the complete article from Cancer Read on »